CytomX Therapeutics Inc (NASDAQ:CTMX)

Delayed Data
As of 3:59pm ET
 -0.01 / -0.80%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for CytomX Therapeutics Inc have a median target of 2.13, with a high estimate of 3.50 and a low estimate of 2.00. The median estimate represents a +71.37% increase from the last price of 1.24.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Hold stock in CytomX Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -952.65%
Growthannually 55.50%


Growthquarterly -50.26%
Growthannually 15.82%
Key to the earnings and sales forecast charts.